Deutsche Bank Ag\ Biolife Solutions Inc Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Biolife Solutions Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 20,803 shares of BLFS stock, worth $543,790. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,803

Previous 16,014 29.91%

Holding current value

$543,790

Previous $343,000 51.6%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$19.19 - $26.52 $91,900 - $127,004	4,789 Added 29.91%	20,803 $520,000
Q2 2024 Aug 14, 2024	SELL	$15.14 - $22.99 $56,169 - $85,292	-3,710 Reduced 18.81%	16,014 $343,000
Q1 2024 May 15, 2024	SELL	$15.35 - $18.82 $10,714 - $13,136	-698 Reduced 3.42%	19,724 $365,000
Q4 2023 Feb 14, 2024	BUY	$8.99 - $16.86 $4,998 - $9,374	556 Added 2.8%	20,422 $331,000
Q3 2023 Nov 09, 2023	SELL	$10.81 - $22.96 $602,571 - $1.28 Million	-55,742 Reduced 73.73%	19,866 $274,000
Q2 2023 Aug 14, 2023	SELL	$17.19 - $24.34 $234,093 - $331,462	-13,618 Reduced 15.26%	75,608 $1.67 Million
Q1 2023 May 15, 2023	BUY	$17.67 - $26.07 $100,842 - $148,781	5,707 Added 6.83%	89,226 $1.94 Million
Q4 2022 Feb 13, 2023	BUY	$16.95 - $25.07 $51,646 - $76,388	3,047 Added 3.79%	83,519 $1.52 Million
Q3 2022 Nov 14, 2022	BUY	$14.64 - $26.7 $109,404 - $199,529	7,473 Added 10.24%	80,472 $1.83 Million
Q2 2022 Aug 11, 2022	BUY	$10.54 - $24.2 $107,845 - $247,614	10,232 Added 16.3%	72,999 $1.01 Million
Q1 2022 May 13, 2022	SELL	$20.81 - $37.29 $498,149 - $892,648	-23,938 Reduced 27.61%	62,767 $1.43 Million
Q4 2021 Feb 11, 2022	BUY	$32.99 - $58.55 $847,612 - $1.5 Million	25,693 Added 42.11%	86,705 $3.23 Million
Q3 2021 Nov 04, 2021	BUY	$42.03 - $60.5 $154,964 - $223,063	3,687 Added 6.43%	61,012 $2.58 Million
Q2 2021 Aug 11, 2021	BUY	$29.51 - $44.62 $400,952 - $606,251	13,587 Added 31.06%	57,325 $2.55 Million
Q1 2021 May 13, 2021	SELL	$32.95 - $44.24 $1.03 Million - $1.38 Million	-31,114 Reduced 41.57%	43,738 $1.57 Million
Q4 2020 Feb 16, 2021	SELL	$27.5 - $45.75 $8.78 Million - $14.6 Million	-319,351 Reduced 81.01%	74,852 $2.99 Million
Q3 2020 Nov 12, 2020	BUY	$16.04 - $28.94 $6.27 Million - $11.3 Million	390,671 Added 11060.9%	394,203 $11.4 Million
Q2 2020 Aug 13, 2020	BUY	$9.2 - $17.06 $9,715 - $18,015	1,056 Added 42.65%	3,532 $58,000
Q1 2020 May 14, 2020	SELL	$8.36 - $17.03 $77,396 - $157,663	-9,258 Reduced 78.9%	2,476 $24,000
Q4 2019 Feb 14, 2020	BUY	$14.59 - $18.9 $142,500 - $184,596	9,767 Added 496.54%	11,734 $189,000
Q3 2019 Nov 14, 2019	SELL	$15.7 - $20.98 $47,932 - $64,051	-3,053 Reduced 60.82%	1,967 $32,000
Q2 2019 Aug 14, 2019	SELL	$15.2 - $19.42 $304,714 - $389,312	-20,047 Reduced 79.97%	5,020 $84,000
Q1 2019 May 15, 2019	BUY	$10.9 - $21.26 $263,518 - $513,981	24,176 Added 2713.36%	25,067 $448,000
Q4 2018 Feb 14, 2019	SELL	$9.5 - $17.17 $248,178 - $448,549	-26,124 Reduced 96.7%	891 $10,000
Q3 2018 Dec 21, 2021	SELL	$14.99 - $25.48 $14 - $25	-1 Reduced -0.0%	27,015 $473,000
Q3 2018 Nov 14, 2018	SELL	$14.99 - $25.48 $1.62 Million - $2.75 Million	-107,984 Reduced 79.99%	27,016 $472,000
Q2 2018 Apr 21, 2020	SELL	$6.18 - $13.49 $6 - $13	-1 Reduced -0.0%	135,000 $1.54 Million
Q2 2018 Aug 14, 2018	BUY	$6.18 - $13.49 $663,101 - $1.45 Million	107,298 Added 387.32%	135,001 $1.54 Million
Q1 2018 Oct 18, 2019	SELL	$4.73 - $6.03 $4 - $6	-1 Reduced -0.0%	27,703 $142,000
Q1 2018 May 15, 2018	SELL	$4.73 - $6.03 $46,808 - $59,672	-9,896 Reduced 26.32%	27,704 $142,000
Q4 2017 Feb 14, 2018	SELL	$4.98 - $6.9 $172,810 - $239,436	-34,701 Reduced 48.0%	37,600 $225,000
Q3 2017 Nov 14, 2017	BUY	$3.45 - $5.71 $249,438 - $412,838	72,301	72,301 $412,000

Others Institutions Holding BLFS

# of Institutions

195

Shares Held

44.8M

Call Options Held

8.2K

Put Options Held

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.12B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account